SCHEMBL2860348

SCHEMBL2860348

COc1nnnc(OC)c1OC

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8642368 0.82 CCNA2 (0.31) ALDH1A1CYP1A2CYP2C19
SCHEMBL10929799 0.82 ALDH1A1 (0.30) ALDH1A1CYP1A2CYP2C19
SCHEMBL2292104 0.73 CYP1A2 (0.35) ALDH1A1CYP1A2CYP2C19
SCHEMBL2370879 0.67 CYP1A2 (0.41) ALDH1A1CYP1A2CYP2C19
SCHEMBL3817132 0.67 PDPK1 (0.45) ALDH1A1CYP1A2CYP2C19
SCHEMBL11592923 0.66 CCNA2 (0.31) ALDH1A1CYP1A2CYP2C19
SCHEMBL11161976 0.64 ALDH1A1 (0.43) ALDH1A1CYP1A2CYP2C19
SCHEMBL8213378 0.62 ALDH1A1 (0.44) ALDH1A1
SCHEMBL3825394 0.57 HPGD (0.33)
SCHEMBL607884 0.54 APLNR (0.40) ALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109971134-A Near infrared light screened film and its manufacturing method 亿高应用材料有限公司 2019-07-05 CN disclosed
CN-105295311-A Near-infrared light-shielding film, method for producing near-infrared light-shielding film, and near-infrared light-shielding composition ZIRCO APPLIED MATERIALS CO LTD 2016-02-03 CN disclosed
US-20100029885-A1 CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH FUJIFILM MANUFACTURING EUROPE B.V. (NL) 2010-02-04 US disclosed
EP-2010396-B1 CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH FUJIFILM MFG EUROPE BV (NL) 2010-01-20 EP disclosed
EP-1298115-B1 PROCESS FOR THE PREPARATION OF POLYHYDRIC ALCOHOLS NAT INST OF ADVANCED IND SCIEN (JP) 2009-08-26 EP disclosed
EP-2010396-A1 CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH FUJIFILM Manufacturing Europe B.V. (NL) 2009-01-07 EP disclosed
WO-2007126314-A1 CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH FUJIFILM MANUFACTURING EUROPE B.V. (NL) 2007-11-08 WO disclosed
EP-1849618-A1 Crosslinked polymer sheets and methods for making such FUJIFILM Manufacturing Europe B.V. (NL) 2007-10-31 EP disclosed
US-6656328-B2 Subjecting a polyhydric alcohol compound having protected hydroxy group(s) to microwave irradiation in presence of basic compound or acid to deprotect the protecting groups of hydroxy group of polyhydric alcohol compound NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2003-12-02 US disclosed
EP-1298115-A1 PROCESS FOR THE PREPARATION OF POLYHYDRIC ALCOHOLS National Institute of Advanced Industrial Science and Technology (JP) 2003-04-02 EP disclosed
US-20020157939-A1 Process for preparation of polyhydric alcohols NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2002-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029885-A1 CROSSLINKED POLYMER SHEETS AND METHODS FOR MAKING SUCH PARG, PARN, COL14A1 ALDH1A1 1223/4885CYP1A2 684/4885CYP2C19 1399/4885
US-20020157939-A1 Process for preparation of polyhydric alcohols ADH1C, ADH1A, ADH5 ALDH1A1 315/4885CYP1A2 1900/4885CYP2C19 2780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.